SEC Info - Cantel Medical LLC - ‘8-K’ for 3/9/21

SEC Info℠

Home

Help

Please Sign In

Cantel Medical LLC – ‘8-K’ for 3/9/21

On: Tuesday, 3/9/21, at 7:56am ET · For: 3/9/21 · Accession #: 19446-21-9 · File #: 1-31337

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/09/21  Cantel Medical Corp.              8-K:2,9     3/09/21   13:504K

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     25K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    110K 
 9: R1          Cover                                               HTML     48K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- cmd-20210309_htm                    XML     23K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.CAL  XBRL Calculations -- cmd-20210309_cal                XML      7K 
 5: EX-101.DEF  XBRL Definitions -- cmd-20210309_def                 XML      9K 
 6: EX-101.LAB  XBRL Labels -- cmd-20210309_lab                      XML     70K 
 7: EX-101.PRE  XBRL Presentations -- cmd-20210309_pre               XML     34K 
 3: EX-101.SCH  XBRL Schema -- cmd-20210309                          XSD     11K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
13: ZIP         XBRL Zipped Folder -- 0000019446-21-000009-xbrl      Zip     33K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

cmd-20210309

i 0000019446 i false i 00000194462021-03-092021-03-0900000194462020-12-082020-12-08

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________________________________________________

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) i March 9, 2021

i CANTEL MEDICAL CORP.

(Exact name of registrant as specified in its charter)


i Delaware	i 001-31337	i 22-1760285
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Identification Number)

i 150 Clove Road

i Little Falls

i New Jersey

i 07424

i (973)

i 890-7220

(Address of principal executive offices)

(Zip code)

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


i Common Stock	i CMD	i New York Stock Exchange
(Title of each class)	(Trading Symbol)	(Name of each exchange on which registered)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange

Act. o

Item 2.02 Results of Operations and Financial Condition

On March 9, 2021, the Registrant issued a press release announcing its results of operations for the quarter ended January 31, 2021 (Registrant’s second quarter of fiscal year 2021). A copy of the press release is included with this Report as Exhibit 99.1.

Item 9.01 Financial Statements, Pro-Forma Financial Information and Exhibits

(d) Exhibit 99.1 Press release of Registrant dated March 9, 2021.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	CANTEL MEDICAL CORP.


	By:	/s/ *George L. Fotiades*
		George L. Fotiades
		Chief Executive Officer

March 9, 2021

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	3/9/21
	1/31/21	10-Q
		List all Filings

↑Top

Filing Submission 0000019446-21-000009 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)